XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $815 | -11.3% | 23,866 | 0.0% | 0.31% | -15.0% |
| Q2 2023 | $919 | -35.8% | 23,866 | -40.3% | 0.37% | -35.0% |
| Q1 2023 | $1,432 | -39.0% | 40,000 | -32.8% | 0.56% | -36.5% |
| Q4 2022 | $2,346 | -99.9% | 59,500 | 0.0% | 0.89% | -2.0% |
| Q3 2022 | $2,148,000 | +18.7% | 59,500 | 0.0% | 0.90% | +18.9% |
| Q2 2022 | $1,810,000 | -11.0% | 59,500 | -10.5% | 0.76% | +17.3% |
| Q1 2022 | $2,033,000 | -24.8% | 66,500 | -23.1% | 0.65% | -29.3% |
| Q4 2021 | $2,702,000 | – | 86,488 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |